Leaflet MULTAQ 400 400mg film-coated tablets
Indicated for: cardiac arrhythmias
Route of administration: oral
Substance: dronedarone (antiarrhythmic)
ATC: C01BD07 (Cardiovascular system | Antiarrhythmics, class I and III | Antiarrhythmics, class III)
This medicine may increase the risk of heart rhythm disturbances.
Dronedarone is an antiarrhythmic medication used for the treatment of paroxysmal or persistent atrial fibrillation, aiming to maintain normal sinus rhythm. It works by blocking potassium, sodium, and calcium channels, stabilizing the heart's electrical activity.
The medication is taken orally, usually twice daily, as directed by a doctor. It is important to monitor cardiac and liver function during treatment.
Side effects may include nausea, diarrhea, fatigue, or skin rash. In rare cases, liver failure or worsening arrhythmias may occur.
Dronedarone is not recommended for patients with severe heart failure, liver failure, or hypersensitivity to this medication.
General data about MULTAQ 400 400mg
- Substance: dronedarone
- Date of latest medicines list: 01-04-2015
- Product code: W55155003
- Concentration: 400mg
- Pharmaceutical form: film-coated tablets
- Quantity: 60
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.